Nuix rev for FY23 was $182.5m, with the growth we know about from the May update that FY24 EBITDA is up 35% and ACV is up 10% on 23 + the one-off insurance sugar-hit. So a 20% Nett Revenue growth is not unreasonable.
What is the PE for this category on $220m Rev and growing conservatively at 15-20% PA?
DYOR.
Nuix rev for FY23 was $182.5m, with the growth we know about...
Add NXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.39 |
Change
-0.080(1.24%) |
Mkt cap ! $2.099B | |||
| Open | High | Low | Value | Volume |
| $6.48 | $6.50 | $6.25 | $5.853M | 920.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3143 | $6.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.39 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NXL (ASX) Chart |